Skip to main content
Improve Medical Instruments CO., Ltd. logo

Improve Medical Instruments CO., Ltd. — Investor Relations & Filings

Ticker · 300030 ISIN · CNE100000JL3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,954 across all filing types
Latest filing 2022-12-12 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300030

About Improve Medical Instruments CO., Ltd.

https://www.improve-medical.com

Improve Medical Instruments CO., Ltd. focuses on the development, production, and distribution of clinical laboratory and nursing solutions. The core product range includes evacuated blood collection systems, specimen collection and transport media, and laboratory automation equipment. The company also provides medical imaging components and point-of-care testing (POCT) systems. By integrating research and development with advanced manufacturing, the organization supports clinical diagnostics and patient care through high-precision tools designed for healthcare facilities and research laboratories. Its offerings are characterized by a commitment to diagnostic safety and efficiency across global markets.

Recent filings

Filing Released Lang Actions
关于变更医疗器械经营许可证的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding the change of a medical device business license by 阳普医疗科技股份有限公司. It details the updated license information, the impact on the company, and risk warnings. There is no financial data, no mention of financial results, no regulatory certifications, or meeting materials. The document is short (1197 characters) and serves as an official announcement of a regulatory change related to the company's business license. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-12-12 Chinese
关于全资子公司取得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (600 characters) from Yangpu Medical Technology Co., Ltd. about its wholly-owned subsidiary obtaining a medical device registration certificate issued by the National Medical Products Administration. It describes the certificate details and the potential impact on the company's business. There is no financial data, no mention of a report being attached or published, and no regulatory form references. This is a regulatory announcement about a product certification, not a financial report or meeting material. It fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2022-11-04 Chinese
第五届董事会第二十次会议决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the company's board of directors regarding the approval of the 2022 third quarter report and the appointment of a securities affairs representative. It includes voting results and references the full 2022 third quarter report published elsewhere. The document itself does not contain the full financial report but announces board decisions and resolutions. This fits the category of Board/Management Information (MANG), as it announces board meeting resolutions and management appointments.
2022-10-25 Chinese
关于聘任证券事务代表的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the appointment of a securities affairs representative (a corporate officer role) at 阳普医疗科技股份有限公司. It includes details about the appointee's qualifications and contact information. There is no financial data, no mention of financial results, no regulatory filings or certifications, and no shareholder voting results. The document is a corporate governance-related announcement about management personnel changes but not about board members or senior management changes per se. It fits best under Board/Management Information (MANG) as it concerns appointment of a key corporate officer related to securities affairs.
2022-10-25 Chinese
第五届监事会第十六次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the supervisory board regarding the approval of the company's 2022 third quarter report. It states that the supervisory board has reviewed and approved the 2022 third quarter report, but the actual report is disclosed separately on the designated information disclosure website. The document itself is short (685 characters) and serves as an announcement of the meeting resolution and approval, not the full interim/quarterly report. Therefore, it is best classified as a Regulatory Filing (RNS) because it does not contain substantive financial data but is an official announcement related to the report.
2022-10-25 Chinese
关于披露2022年第三季度报告的提示性公告
Report Publication Announcement Classification · 95% confidence The document is a short announcement (380 characters) indicating that the company has approved its 2022 third quarter report and that the report has been published on an official disclosure website. It does not contain the actual financial data or detailed report content but serves as a notice to investors to review the full report elsewhere. According to the 'MENU VS MEAL' rule, such a brief notice about the report's availability is classified as a Report Publication Announcement (RPA).
2022-10-25 Chinese

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.